Researchers from the California Department of Health presented data at the 2019 annual meeting of the American Society of Microbiology (ASM) demonstrating that a single highly resistant bacterial strain persisted within the ICU of a northern California hospital for over three years, infecting numerous patients admitted to the ICU.
C. auris infections have become increasingly common, and they are more frequently resistant to antifungal drugs doctors use to treat them. Scientists have been attempting to determine the origin of C. auris, but it has been difficult because the pathogen seems to have appeared in several places around the world simultaneously.
Trehalose, a type of carbohydrate (sugar), could hold the key to a new treatment for diabetes and other metabolic diseases, but it might also fuel more severe Clostridium difficile (C. difficile) infections.
By John Shultz Randy Rasmussen, CEO of BioFire Diagnostics, delivered the keynote speech at the 2018 bioMérieux “Night at the Museum” event held in Salt Lake City, Utah on July 9th, 2018. In his talk, Randy relates the challenges he has faced in his own career in the fight against infectious disease, while reflecting on …